Novartis and Access Industries unit Clal Biotechnology Industries both took part in the neurological disorder drug developer's series B round.

Busy Burr has moved on from her position as head of corporate venturing unit Humana Health Ventures as Humana reorganises its VC stakes.

Dundee spinout Kinetic Discovery has been picked up by its peer Exscientia in a deal consolidating the equity of Frontier IP, which held stakes in both drug discovery companies.

M Ventures led a series A round for UNC's RNA therapy spinout, while Amgen, Illumina, AbbVie and Mitsubishi Tanabe Pharma also took part.

Vrije Universiteit Brussel’s Camel-IDS collected funding from investors including Novo for a radiation-based oncology platform that will initially target Her2-positive brain metastatic breast cancer.

Vrije Universiteit Brussel’s Camel-IDS collected funding from investors including Novo for a radiation-based oncology platform that will initially target Her2-positive brain metastatic breast cancer.

University of Louisville Foundation alleges its spinout pharmacogenetics spinout PGxL was unable to repay a loan it had guaranteed after the business fell into bankruptcy.

Tokyo telemedicine spinout Miup has been backed by Beyond Next Ventures in its bid to build an AI-powered healthcare ecosystem in Bangladesh.

Merck Group's M Ventures unit led the RNA therapy startup's series A round, which featured Amgen, Illumina, AbbVie and Mitsubishi Tanabe Pharma.

PeptiDream has led immuno-oncology drug developer Kleo Pharmaceuticals’ series B round, which also featured existing investor Biohaven.